Efficacy Studies against PCV-2 of a New Trivalent Vaccine including PCV-2a and PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Weeks of Age

This study aimed to evaluate the efficacy of a new trivalent vaccine containing inactivated Porcine Circovirus 1-2a and 1-2b chimeras and a Mycoplasma hyopneumoniae bacterin administered to pigs around 3 weeks of age. This trivalent vaccine has already been proved as efficacious in a split-dose regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pleguezuelos, Patricia, Sibila, Marina, Ramírez, Carla, López-Jiménez, Rosa, Pérez, Diego, Huerta, Eva, Llorens, Anna Maria, Pérez, Mónica, Correa-Fiz, Florencia, Mancera Gracia, José Carlos, Taylor, Lucas P., Smith, Jennifer, Bandrick, Meggan, Borowski, Stasia, Saunders, Gillian, Segalés, Joaquim, López-Soria, Sergio, Fort, Maria, Balasch, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784864/
https://www.ncbi.nlm.nih.gov/pubmed/36560518
http://dx.doi.org/10.3390/vaccines10122108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784864/
https://www.ncbi.nlm.nih.gov/pubmed/36560518
http://dx.doi.org/10.3390/vaccines10122108

Ejemplares similares